U.S. Markets close in 1 min.

Taro Pharmaceutical Industries Ltd. (TARO)


NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
116.18+2.16 (+1.89%)
As of 3:59PM EDT. Market open.
People also watch
LCISCRIIPXLUTHRPRGO
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue3/31/20163/31/20153/31/2014
Total Revenue950,751862,944759,285
Cost of Revenue171,785186,359179,279
Gross Profit778,966676,585580,006
Operating Expenses
Research Development71,16065,51055,430
Selling General and Administrative93,33883,44494,323
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss614,468527,631430,253
Income from Continuing Operations
Total Other Income/Expenses Net22,35254,04913,654
Earnings Before Interest and Taxes636,820581,680443,907
Interest Expense---
Income Before Tax636,820581,680443,907
Income Tax Expense95,31396,05982,729
Minority Interest6,0025,6635,086
Net Income From Continuing Ops541,507485,621361,178
Non-recurring Events
Discontinued Operations-236-787-319
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income540,932484,257360,387
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares540,932484,257360,387